Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Accepts healthy volunteers

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

ClinicalTrials.gov ID: NCT06299098

Public ClinicalTrials.gov record NCT06299098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 6:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study of The Efficacy and Safety of Trevogrumab, With or Without Garetosmab, in Addition to Semaglutide in Patients With Obesity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (Wegovy®). This study will be done in 3 parts, Part A, Part B, and Part C where different study drugs will be tested. Part A of the study is focused on healthy participants. Part B and C of the study is focused on participants with obesity. The aim of Part A of the study is to see how safe and tolerable the study drug is in healthy participants. The aim of Part B and Part C of the study is to see how safe and effective the study drug is when combined with Wegovy. Parts A, B, and C of the study are looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

Study identification

NCT ID
NCT06299098
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
1,005 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 13, 2024 (Actual)
Primary completion
Jun 16, 2026 (Actual)
Completion
Oct 21, 2026 (Estimated)
Last update posted
Sep 1, 2026

2024 – 2026

United States locations

U.S. sites
58
U.S. states
25
U.S. cities
54
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207 —
Cullman Clinical Trials Cullman Alabama 35055 —
Foothills Research Center Cct Research Phoenix Arizona 85044 —
Anaheim Clinical Trials Anaheim California 92801 —
ProSciento Chula Vista California 91911 —
Valiance Clinical Research- Huntington Park Huntington Park California 91356 —
Velocity, San Diego La Mesa California 91941 —
Northern California Research Sacramento California 95821 —
Acclaim Clinical Research San Diego California 92120 —
Metabolic Institute of America Tarzana California 91356 —
Valiance Clinical Research Tarzana California 91356 —
Southwest General Healthcare Center Fort Myers Florida 33907 —
Westside Center for Clinical Research Jacksonville Florida 32205 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
IMA Clinical Research St. Petersburg St. Petersburg Florida 33709 —
Precision Clinical Research, LLC Sunrise Florida 33351 —
Clinical Research of West Florida, Inc. Tampa Florida 33606 —
Clinical Research of Central Florida - Bond Clinic Winter Haven Florida 33880 —
Center for Advanced Research and Education Gainesville Georgia 30501 —
Balanced Life Health Care Solutions Lawrenceville Georgia 30046 —
North Georgia Clinical Research Woodstock Georgia 30189 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Elite Clinical Trials LLLP Blackfoot Idaho 83221 —
Prairie Education and Research Cooperative (PERC) Springfield Illinois 62701 —
The South Bend Clinic Center for Research South Bend Indiana 46617 —
Cotton O'Neil Clinical Research Center Topeka Kansas 66606 —
L-MARC Research Center Louisville Kentucky 40213 —
Tandem Clinical Research GI, LLC Marrero Louisiana 70072 —
IMA Clinical Research Monroe - Armand Monroe Louisiana 71201 —
Mayo Clinic Rochester Minnesota 55905 —
Prime Health and Wellness Clinic Fayette Mississippi 39069 —
Olive Branch Family Medical Center Olive Branch Mississippi 38654 —
Sky Integrative Medical Center Skycrng Ridgeland Mississippi 39157 —
Jefferson City Medical Group Jefferson City Missouri 65109 —
Clinvest Research Springfield Missouri 65807 —
Mercury Street Medical Group, PLLC Butte Montana 59701 —
Hassman Research Institute Berlin New Jersey 08009 —
Accellacare Clinical Research, Raleigh Medical Group Raleigh North Carolina 27609 —
Accellacare of Salisbury Salisbury North Carolina 28144 —
Accellacare of Piedmont, Piedmont Healthcare Statesville North Carolina 28625 —
Pmg Research of Wilmington Llc Wilmington North Carolina 28401 —
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103 —
Javara Incorporated at Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Velocity Clinical Research Inc. Cincinnati Ohio 45219 —
AMR Norman Norman Oklahoma 73069 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Tribe Clinical Research Llc Greenville South Carolina 29607 —
PMG Research of Charleston Mt. Pleasant South Carolina 29464 —
Pmg Research of Bristol Bristol Tennessee 37620 —
Chattanooga Medical Research Chattanooga Tennessee 37412 —
PMG Research of Knoxville - Merchant Drive Knoxville Tennessee 37912 —
PMG Research of Knoxville - Emory Road Knoxville Tennessee 37938 —
Velocity Clinical Research Dallas Dallas Texas 75230 —
Medresearch Inc El Paso Texas 79902 —
Valley Institute of Research Fort Worth Texas 76164 —
Consano Clinical Research Shavano Park Texas 78231 —
Charlottesville Medical Research Charlottesville Virginia 22911 —
Health Research of Hampton Roads, Inc. Newport News Virginia 23606 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06299098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2026 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06299098 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →